Menu
+
+
+
+
+
+
Promiliad granted Spero a worldwide, exclusive sublicense to develop and commercialize dihydrofolate reductase (DHFR) inhibitors that target Gram-positive and -negative bacteria, fungi and protists. According to Spero, Promiliad...
BioCentury employs a fully integrated multimedia platform — including publications, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.
